Neurology · 2006 · 111 citations · 12 references
Life SciencesNeurologyNeuroscienceMovement DisordersNeuroimmunologyNeuropathologyAutoimmune Neurological DisordersCerebellar SystemsGait DisordersGait ImpairmentAnti-glutamic Acid Decarboxylase AntibodiesAtaxia SyndromesAutoimmune Cerebellar AtaxiaCerebellar DiseaseCerebellar DysfunctionGamma-aminobutyric Acid ModulatorsGlutamic Acid Decarboxylase AntibodiesStiff-person Syndrome
We report five of 38 patients with stiff person syndrome (SPS), who also had cerebellar disease, gait ataxia, dysarthria, and oculomotor dysfunction (SPS-Cer). Cerebellar manifestations either preceded SPS or occurred concurrently. Brain MRI was normal. The intrathecal production of glutamic acid decarboxylase antibodies was elevated. Gamma-aminobutyric acid-enhancing drugs and immunotherapies improved only the stiffness. SPS-Cer is a distinct subset of SPS causing a more severe and complex clinical phenotype.
12
High-Dose Intravenous Immune Globulin for Stiff-Person Syndrome
Marinos C. Dalakas, Mavis Fujii, Mian Li et al. · New England Journal of Medicine · 2001 · 436 citations
Life Sciences, Immunology, Neurology +13
Cerebellar Ataxia With Anti–Glutamic Acid Decarboxylase Antibodies
Jérôme Honnorat, Albert Saiz, Bruno Giometto et al. · Archives of Neurology · 2001 · 384 citations
Medicine, Endocrinology, Neurology +15
The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome
Marinos C. Dalakas, Mavis Fujii, Mian Li et al. · Neurology · 2000 · 332 citations · Full text
Marinos C. Dalakas, Mian Li, Mavis Fujii et al. · Neurology · 2001 · 214 citations